[HTML][HTML] Transforming growth factor-β2 downregulates major histocompatibility complex (MHC) I and MHC II surface expression on equine bone marrow-derived …
AK Berglund, MB Fisher, KA Cameron… - Frontiers in Veterinary …, 2017 - frontiersin.org
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived …
AK Berglund, MB Fisher, KA Cameron… - Frontiers in Veterinary …, 2017 - europepmc.org
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
[HTML][HTML] Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived …
AK Berglund, MB Fisher, KA Cameron… - Frontiers in Veterinary …, 2017 - ncbi.nlm.nih.gov
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
[HTML][HTML] Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived …
AK Berglund, MB Fisher, KA Cameron, EJ Poole… - 2017 - madbarn.com
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
Transforming growth factor-β2 downregulates major histocompatibility complex (MHC) I and MHC II surface expression on equine bone marrow-derived mesenchymal …
AK Berglund, MB Fisher, KA Cameron, EJ Poole… - 2017 - cabidigitallibrary.org
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived …
AK Berglund, MB Fisher… - Frontiers in …, 2017 - pubmed.ncbi.nlm.nih.gov
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
Transforming Growth Factor-β2 Downregulates Major Histocompatibility Complex (MHC) I and MHC II Surface Expression on Equine Bone Marrow-Derived …
AK Berglund, MB Fisher, KA Cameron, EJ Poole… - 2017 - agris.fao.org
Allogeneic mesenchymal stem cells (MSCs) are a promising cell source for treating
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …
musculoskeletal injuries in horses. Effective and safe allogeneic therapy may be hindered …